Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Elixxer Ltd. V.QBA


Primary Symbol: V.ELXR

Elixxer Ltd is a Canada based company engaged in growing and producing medical-grade cannabis. It focuses on making investments in Nutraceuticals, Cosmetics, Pharma, and Cultivation and Extraction sectors.


TSXV:ELXR - Post by User

<< Previous
Bullboard Posts
Next >>
Post by keeniinvestoron May 29, 2019 2:37pm
88 Views
Post# 29782457

444 days later ...

444 days later ...

2019-05-29 11:29 PT - News Release

 

MONTREAL, May 29, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSXV: LG) (OTCQB: LGGCF) ("LGC" or the “Corporation”) announces it has closed its previously announced transaction with 9379-1432 Qubec Inc., the Canadian incorporated parent company of Evolution BNK and Evolution ATM (collectively referred to as “Evolution”).

On 13 August 2018, LGC and Evolution entered into a convertible debenture indenture agreement (the “Loan”) for Euro 3 million. The Loan, the proceeds of which have been paid over to Evolution, is convertible into a 49% equity interest in Evolution and bears interest at the rate of 10%. 

Evolution is a legal cannabis (less than 0.2% THC) cultivation facility based in Pavia, Italy. Evolution is completing the retrofit of its 22,000 sq. ft. indoor facility within their 70,000 sq. ft. compound in Pavia, Italy for the production of high CBD, low (<0.2%) THC cannabis. Tests have been consistently positive as the product is well within the legal THC content set by the Italian Ministry of Health.  Estimated margins will be greater than 50% due to its patented energy usage technology and is well placed for any margin compression expected in Europe. 

Mazen Haddad, CEO LGC Capital “The value driver for Evolution is its low cost cultivation capacity which may offer synergistic benefits for other LGC investee companies like Viridi and announced investee, EasyJoint who will require high quality, compliant product to meet the estimated demands from the European cannabis light and CBD markets.” 

<< Previous
Bullboard Posts
Next >>